Fine-scale mapping of chromosome 9q22.33 identifies candidate causal variant in ovarian cancer

PeerJ. 2024 Feb 14:12:e16918. doi: 10.7717/peerj.16918. eCollection 2024.

Abstract

Ovarian cancer is a complex polygenic disease in which genetic factors play a significant role in disease etiology. A genome-wide association study (GWAS) identified a novel variant on chromosome 9q22.33 as a susceptibility locus for epithelial ovarian cancer (EOC) in the Han Chinese population. However, the underlying mechanism of this genomic region remained unknown. In this study, we conducted a fine-mapping analysis of 130 kb regions, including 1,039 variants in 200 healthy women. Ten variants were selected to evaluate the association with EOC risk in 1,099 EOC cases and 1,591 controls. We identified two variants that were significantly associated with ovarian cancer risk (rs7027650, P = 1.91 × 10-7; rs1889268, P = 3.71 × 10-2). Expression quantitative trait locus (eQTL) analysis found that rs7027650 was significantly correlated with COL15A1 gene expression (P = 0.009). The Luciferase reporter gene assay confirmed that rs7027650 could interact with the promoter region of COL15A1, reducing its activity. An electrophoretic mobility shift assay (EMSA) showed the allele-specific binding capacity of rs7027650. These findings revealed that rs7027650 could be a potential causal variant at 9q22.33 region and may regulate the expression level of COL15A1. This study offered insight into the molecular mechanism behind a potential causal variant that affects the risk of ovarian cancer.

Keywords: Expression quantitative trait locus analysis; Fine-scale mapping; Functional annotation; Genetic variants; Ovarian cancer.

MeSH terms

  • Carcinoma, Ovarian Epithelial / genetics
  • Chromosome Structures
  • Female
  • Genetic Predisposition to Disease* / genetics
  • Genome-Wide Association Study
  • Humans
  • Ovarian Neoplasms* / genetics
  • Quantitative Trait Loci / genetics

Grants and funding

This work was supported by the National Key R&D Program of China (2021YFC2500400), the National Natural Science Foundation of China (81973113), the National Human Genetic Resources Sharing Service Platform (2005DKA21300), the National Key Research and Development Program of China, the Net Construction of Human Genetic Resource Bio-bank in North China (2016YFC1201703), and the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.